On Tuesday, Kobayashi Pharmaceutical announced that it had discovered an additional 11 fatalities that ought to have been reported to the health ministry due to potential connections to dietary supplements that contained its red fermented rice, known as Beni Koʄji..
The 11 cases had been classified into a wrong category in the process of sorting out the inquiries made to its call center, the company said, explaining the reason for failing to report them properly.There was a flaw in the firm’s system to confirm damage reports, Kobayashi Pharmaceutical President Satoshi Yamane said in an online press conference. “We sincerely apologize for this,” he said.
The company is based in Osaka, western Japan, and later confirmed that five of the 11 victims did not take the supplements in question.
However, the company stated that the remaining six cases will be looked into because it is impossible to completely rule out any connection between them and the supplement intake.
